Skip to content
Clinical Trial Events
LSX Investival Showcase London 2026

Panel Headliner Stage track

Where Has AI Been Most Effective in Life Sciences? Lessons Learned and the Path Forward

Mon, Nov 16, 2026 · 2:00–2:45 PM GMT Old Billingsgate

About this session

The promise of AI is vast, but the reality is more nuanced. This session provides a candid assessment of where artificial intelligence has truly delivered tangible results in life sciences—and where it has fallen short of the hype. More importantly, we'll explore where AI is heading next and which emerging applications represent the greatest opportunities for innovation and investment. Our expert panellists will examine AI's track record across drug discovery, clinical development, and commercialization, while mapping out the next frontier of AI-enabled breakthroughs.

Speakers

  • Megan McMellon

    Senior Associate, Commercial IP · A&O Shearman

    Moderator

  • Carl Firth

    Partner · Panacea Capital

    Panelist

  • Piotr Surma

    CEO · Ingenix

    Panelist

  • Jue Wang

    VP, Global Head of Business Development · Insilico Medicine

    Panelist

  • Winston Haynes

    VP Computational Sciences and Engineering · LabGenius Therapeutics

    Panelist